Hereditary transthyretin cardiac amyloidosis proven by endomyocardial biopsy : a single-centre retrospective study and literature review
BACKGROUND: This study aimed to report the genotypes and phenotypes of hereditary transthyretin cardiac amyloidosis (hATTR-CA) in a Western Chinese cohort and review the genetic profiles of this disorder in the Chinese population.
METHODS: Transthyretin (TTR) gene sequencing of probands diagnosed with TTR cardiac amyloidosis and their relatives was performed at West China Hospital of Sichuan University from January 2018 to December 2021. All patients underwent endomyocardial biopsy for light and electron microscopy examinations. Clinical and essential examination materials were retrospectively collected and analysed.
RESULTS: TTR gene alteration was demonstrated in five probands and their two relatives. Three TTR variants were identified, namely, Ser23Asn, Glu54Leu and Thr60Ala. This study is the first to report Glu54Leu as pathogenic mutations in Chinese hATTR-CA patients. The Ser23Asn mutation was the most common mutation in this cohort. Five probands, including two males and three females, were all ethnic Han-Chinese. The median age at diagnosis and delay in diagnosis (interval from onset to diagnosis) was 56 years (range, 54-69 years) and 8 years (range, from 1 to 30 years), respectively. Three cases showed a defined family history of amyloidosis. Endomyocardial biopsies and TTR immunohistochemistry showed positive results in all patients. Two probands died 17.0 months and 21.0 months after diagnosis.
CONCLUSIONS: We identified one novel TTR variants causing hATTR-CA in the West Han Chinese population. To avoid misdiagnosis or delayed diagnosis of hATTR-CA, TTR genotypic screening and endomyocardial biopsy should be performed as soon as possible in cases with heightened clinical suspicion.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Acta cardiologica - (2023) vom: 28. Sept., Seite 1-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yu, Tian-Ping [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cardiac amyloidosis |
|---|
| Anmerkungen: |
Date Revised 28.09.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1080/00015385.2023.2257521 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362643962 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362643962 | ||
| 003 | DE-627 | ||
| 005 | 20231226091650.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/00015385.2023.2257521 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1208.xml |
| 035 | |a (DE-627)NLM362643962 | ||
| 035 | |a (NLM)37768132 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yu, Tian-Ping |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hereditary transthyretin cardiac amyloidosis proven by endomyocardial biopsy |b a single-centre retrospective study and literature review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a BACKGROUND: This study aimed to report the genotypes and phenotypes of hereditary transthyretin cardiac amyloidosis (hATTR-CA) in a Western Chinese cohort and review the genetic profiles of this disorder in the Chinese population | ||
| 520 | |a METHODS: Transthyretin (TTR) gene sequencing of probands diagnosed with TTR cardiac amyloidosis and their relatives was performed at West China Hospital of Sichuan University from January 2018 to December 2021. All patients underwent endomyocardial biopsy for light and electron microscopy examinations. Clinical and essential examination materials were retrospectively collected and analysed | ||
| 520 | |a RESULTS: TTR gene alteration was demonstrated in five probands and their two relatives. Three TTR variants were identified, namely, Ser23Asn, Glu54Leu and Thr60Ala. This study is the first to report Glu54Leu as pathogenic mutations in Chinese hATTR-CA patients. The Ser23Asn mutation was the most common mutation in this cohort. Five probands, including two males and three females, were all ethnic Han-Chinese. The median age at diagnosis and delay in diagnosis (interval from onset to diagnosis) was 56 years (range, 54-69 years) and 8 years (range, from 1 to 30 years), respectively. Three cases showed a defined family history of amyloidosis. Endomyocardial biopsies and TTR immunohistochemistry showed positive results in all patients. Two probands died 17.0 months and 21.0 months after diagnosis | ||
| 520 | |a CONCLUSIONS: We identified one novel TTR variants causing hATTR-CA in the West Han Chinese population. To avoid misdiagnosis or delayed diagnosis of hATTR-CA, TTR genotypic screening and endomyocardial biopsy should be performed as soon as possible in cases with heightened clinical suspicion | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cardiac amyloidosis | |
| 650 | 4 | |a endomyocardial biopsy | |
| 650 | 4 | |a hereditary | |
| 650 | 4 | |a transthyretin | |
| 700 | 1 | |a Hou, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ting-Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xue-Qin |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yu-Cheng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta cardiologica |d 1946 |g (2023) vom: 28. Sept., Seite 1-8 |w (DE-627)NLM000152854 |x 1784-973X |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:28 |g month:09 |g pages:1-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/00015385.2023.2257521 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 28 |c 09 |h 1-8 | ||